Medicine
Calcium acetate 667 mg tablet
Calcium acetate 667 mg tablet is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F) excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Calcium acetate
- Brand
- Sold under the generic name
- Strength
- 667 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 200 tablets
- Manufacturers
- Avet PharmaceuticalsIndiaChartwell RX
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F) excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AE07 Calcium acetate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 January 2015
- Identifiers
- RxCUI 197433DailyMed set ID ac4975aa-0ee9-4473-81e2-839f1556e684, 9584350a-b6ad-45ae-b1c5-c8ca8f471c03NDC 23155-621, 62135-192Application ANDA202885, ANDA202420
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 200 tablet in 1 bottle | 23155-621-02 | Avet PharmaceuticalsIndia | 22 January 2015 |
| 200 tablet in 1 bottle | 62135-192-22 | Chartwell RX | 1 July 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 December 1990 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Calcium acetate
Clinical summary
Calcium acetate is a blood coagulation factor indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). It is available as capsules and tablets for oral use. MedsAcross supplies Calcium acetate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Calcium acetateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Calcium Acetate prescribing information (Rising Pharma Holdings) · U.S. National Library of Medicine, DailyMed
Need Calcium acetate 667 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.